Recent Characterization of Key Proteins to Combat Tuberculosis.

Area of Science:

• Microbiology
• Proteomics
• Molecular Biology

Background:

• Mycobacterium tuberculosis (Mtb) proteome comprises canonical proteins and microproteins.
• Microproteins, translated from small ORFs, regulate bacterial growth, persistence, and antibiotic response.
• Conserved hypothetical proteins (CHPs) are increasingly recognized for vital roles in Mtb biology.

Purpose of the Study:

• To delineate canonical proteins and microproteins in Mtb.
• To understand the roles of microproteins and CHPs in Mtb adaptation and pathogenesis.
• To identify potential vaccine candidates, drug targets, and diagnostic biomarkers from newly characterized Mtb proteins.

Main Methods:

• Large-scale proteogenomic analyses of Mtb.
• Structural and functional characterization of microproteins and CHPs.
• Assessment of immunogenicity, essentiality, and infection-specific expression.

Main Results:

• Mtb proteome includes canonical proteins and microproteins with diverse functions.
• Microproteins and CHPs are key modulators of Mtb growth, persistence, and stress adaptation.
• Newly characterized microproteins and CHPs show promise as vaccine candidates, drug targets, and diagnostic biomarkers.

Conclusions:

• Mtb possesses remarkable proteomic versatility for adaptation and persistence.
• Microproteins and CHPs expand our understanding of Mtb pathogenesis.
• These novel proteins offer significant potential for therapeutic and diagnostic strategies against Mtb infections.